Connect with us

Cannabis News

Bipartisan Majority Of American Voters Support Marijuana Legalization, New Poll Finds After Trump Orders Rescheduling

Published

on

A two-fold majority of American voters across nearly every major demographic — age, race, gender and political affiliation — support legalizing marijuana, according to a new poll released just days ago. President Donald Trump issued an executive order to agencies to further reform cannabis rescheduling..

The poll, conducted by JL Partners and commissioned by The Daily Mail, showed that 53 percent of registered US voters support legalization. This includes 62% of Democrats and 51% of Republicans.

The poll simply asked, “Would you be for or against the legalization of marijuana?”

While there was majority support among all age demographics, 30-49 year olds had 61 percent support. But even 50 percent of the over-65s, historically the most conservative age group, favor policy change.

58% of men are in favor of legalization, and 50% of women are in favor of reform.

The survey Between December 20 and 21, there were interviews with 1,000 registered voters. This means that Trump has asked the attorney general to declare marijuana under Title III of the Controlled Substances Act (CSA).

The move would not have federally legalized cannabis, and administration officials stressed at the signing ceremony of the reorganization order that legalization was not their intention.

However, what the reorganization would do is symbolically recognize marijuana’s medical value, allow cannabis companies to take federal tax deductions, and loosen some research barriers related to Schedule I drugs.

A recent Daily Mail poll comes with growing bipartisanship over legalizing marijuana in general, but Another recent YouGov poll found Republicans evenly split on the issue41% in favor and 41% against the wider reform.

However, a bipartisan majority of Americans said in that poll that they support federally rescheduling marijuana.

Additionally, a majority (76%) of respondents to the YouGov survey also said marijuana either “definitely” (43%) or “probably” (33%) has “legitimate medical uses.” There was also a bilateral agreement on that question. Most Democrats said cannabis has medical value (84%), followed by independents (74%) and Republicans (73%).


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

The reorganization process started by the Biden administration, which Trump has now called for an end, is still pending. Congressional researchers also recently released a report indicating that there is a possibility The Justice Department may choose to restart the process, or even not complete it. But according to previous polls, reform across the corridor is politically popular.

The president said this month that cannabis can “make people feel a lot better.” It serves as a “substitute for addictive and potentially deadly opioid painkillers.” He clarified, however, that he personally has no interest in using marijuana himself.

So does Trump He dismissed the concerns of GOP lawmakers who oppose the reconsiderationstating that an overwhelming majority of Americans support reform and that cannabis can help people with serious health problems—including his personal friends.

Photo by Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Cresco Labs gets Texas license

Published

on

By











Cresco Labs has obtained a Texas Compassionate Use Program License. It is a vertically integrated license that allows Cresco Labs to cultivate, process and distribute medical cannabis.

“Texas patients deserve access to consistent, quality medicine, and we’re excited. Our track record in medical markets reflects our ability to build strong programs that put patients and communities first,” said Charlie Bachtell, CEO of Cresco Labs. “Winning a license in Texas through a merit-based application demonstrates Cresco Labs’ deep regulatory expertise and thoughtful approach to meaningful local engagement. Organic licenses enable capital-efficient market entry, and our cash flow and balance sheet give us the financial flexibility to invest in and grow our scaled platform for the long term.”

This license advances Cresco Labs’ state-by-state growth strategy and ensures access to one of the largest patient populations in the United States. Texas is the nation’s second most populous state, approaching 30 million people, and continues to see ongoing legislative efforts to improve patient access and expand eligibility.










Continue Reading

Cannabis News

Missouri Lawmakers Pass Bill To Ban Intoxicating Hemp THC Products, Sending It To Governor

Published

on

By

The legislation also includes provisions to protect the privacy of marijuana users and the right of cannabis workers to unionize.

By Rebecca Rivas, Missouri Independent

It would be a bill headed to the desk of Missouri Governor Mike Kehoe (R). remove all intoxicating hemp products from the shelves as of Nov. 12 — including THC seltzers currently sold in bars and grocery stores — in line with the state’s upcoming federal ban.

If Congress were to reverse course and decide to allow the sale of these products, Missouri would allow the sale of marijuana only in licensed dispensaries. And if Congress decides to delay the ban for a couple of years, Missouri would ban all products except liquor sales at dispensaries.

The House passed the bill sponsored by state Rep. Dave Hinman, R-O’Fallon, by a vote of 126 to 23. It passed the Senate Tuesday night and now goes to the governor for his signature or veto.

The bill also includes provisions to protect the privacy of marijuana users and the right of cannabis workers to organize, amendments that state senators added late Tuesday.

Hinman’s legislation was one of the first bills to pass the House this year. He previously told The Independent that the legislation was a priority for state leadership, including the governor, attorney general and House speaker.

Intoxicating hemp products containing as much as 1,000 mg of THC are being sold in smoke shops—outside of licensed marijuana dispensaries in Missouri—and are not regulated by any government agency. Missouri lawmakers have not passed legislation regulating these products since 2023.

The bill comes amid uncertainty about where the federal government will take regulation of these products.

President Donald Trump signed an executive order in December directing his administration to work with Congress to develop a framework that allows full-spectrum CBD products that contain some amount of THC.

On Wednesday, the Centers for Medicare and Medicaid Services unveiled an initiative that could $500 cover per year per 3mg hemp-derived THC and CBD product. for eligible users. Products under this program would be illegal in Missouri under the bill passed Thursday.

This story was first published by the Missouri Independent.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

“There is more to Portugal’s medical cannabis story than recent turbulence”

Published

on

By

Germany imported 2025 tons of medical cannabis. Part of that volume came from a Portuguese processor whose license had been revoked, which was unloaded below cost as it was reinstated. The episode sparked attention, and consequences followed. PTMC’s Joao Duarte believes that most of these conclusions are wrong. “Eight tons is not even 5% of what Germany consumes per year,” he says. “For that to result in price dumping, the math just doesn’t work.”

Structural price pressure
According to him, the price pressure in Portugal is mainly structural. “The more countries that get into production and start exporting, the lower the prices will be. Today, Colombia is exporting, Costa Rica is exporting, and Brazil, with the scale it can bring to outside cultivation, is not far behind. Canada has been the main volume supplier to markets in Germany, Australia, Israel and the UK due to the strength of low-priced flowers from European producers. Again, and fast.” It draws a direct line with what happened in the CBD market in previous years, when prices were compressed as supply expanded and operators without cost or quality advantages found themselves without a market. Medical flower THC, he says, is following the same logic over a longer timeline.

To lift the burden of this price pressure, the answer obviously lies in the right regulations and policies. These should be based on the principles of providing high quality medicines to patients. To achieve this, the flowers must reach the consumers shortly after they are picked. As simple as it sounds, proximity is Portugal’s real advantage. “The fresher the flower is when it reaches the patient, the better the quality,” he says. “Only proximity gives that.”

© Henner Damke | Dreamstime

A turning point
As for the regulatory issue, Joao points to Portugal’s eight-year history of medical cannabis as a distinguishing feature, following last year’s police raids. Organizations that have long been involved in the licensing and enforcement framework have developed standards and experience in applying them. “Our GMP standards are real,” he says. “They are not a number on a certificate.”

The damage to the reputation of these raids, in his opinion, is exaggerated. “There is always a scandal in the industry,” he said. “That doesn’t necessarily mean it’s over, that a country’s economic sector has been kicked out. Canada, the largest exporter of cannabis, is the clearest example of that. Everyone remembers the CannTrust scandal in 2019, which made international headlines. That didn’t kill the Canadian industry until it became them, the regulatory system moved in their work. It looks like.”

EU-GMP clearance
One important area is EU GMP clearance, the practice of converting imported flowers through a European facility to obtain certification that the original material would not otherwise carry. “We would have more value growing the flowers than doing the conversion,” he says. For Portuguese producers, the practice reduces the premium that EU GMP certification must entail and makes it more difficult to distinguish domestically grown product from processed imports at the point of sale.

To each his own
Joao does not believe that other European countries can take Portugal’s place in the old continent’s cannabis industry. “This is simply because it’s not one thing for a country to be active in one sector and then push out another. It’s an open market, everyone participates at different levels.” As a neighbor, Joao cites Spain as an example. The country currently has less than ten licensed producers and has yet to build the export infrastructure or regulatory track required by the markets. “I don’t see Spain coming and taking over,” he says. “Both Spain and Portugal will take market share. Operators with established contracts will continue to move product. After that, it’s about quality and price.”

Denmark, he says, is an immediate competitive variable, producing significant quantities and moving into European markets with momentum. Portugal is currently among the top three to five exporters to Germany and has established positions in Australia, Israel and the United Kingdom. “This reflects accumulated capacity rather than regulatory time, and it’s not something that goes away because a processor loses its license,” he says.

A common European pricing policy, along the lines of the state-controlled model in France, is a mechanism that the industry should collectively push for. Without this, individual producers are left to absorb the cost pressures of suppliers operating on a scale that European policy has no current framework for. “We should aim to have good flowers,” he says. “We must not aim to demolish Portugal.”

For more information:
PTMC
ptmc.pt

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media